Previous Close | 2.5150 |
Open | 2.5350 |
Bid | 2.5600 x 250000 |
Ask | 2.5850 x 250000 |
Day's Range | 2.5350 - 2.5350 |
52 Week Range | 2.4400 - 4.0150 |
Volume | |
Avg. Volume | 190 |
Market Cap | 393.25M |
Beta (5Y Monthly) | 0.61 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3800 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Regulated information – May 9, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2023: HealthCare IT: Increase in order intake of 25%, 4.8% revenue increaseProfitability impacted by cost inflation and unfavorable mix effects Digital Print & Chemicals: Growth driven by Digital Printing and Zirfon membranesSuccessful price increase actions and cost reductions allowed to restore profitability Radiology Solutions: Medical film: volume recovery in China but continuing margin pressure and geopolitical
Agfa-Gevaert Group completes the sale of its Offset Solutions division to AURELIUS Group Mortsel, Belgium – April 4, 2023 – 7.45 a.m. CET The Agfa-Gevaert Group has successfully completed the sale of its Offset Solutions division to the alternative investment firm AURELIUS Group. Under the terms of the share purchase agreement with AURELIUS Group, the Agfa-Gevaert Group will continue to provide certain consumables (including film) and services to its former division. “The sale of our Offset Solu
Agfa to invest in new industrial unit for Zirfon membranes for green hydrogen production Mortsel, Belgium – March 8, 2023 – 7.45 a.m. CET Agfa today announced that, given the strong increase in demand, the Board of Directors validated the investment for a new industrial unit for the company’s Zirfon membranes for green hydrogen production, next to further investments in growing the current facility. The unit will be installed in existing buildings at the company’s site in Mortsel, Belgium. When
Regulated information – March 8, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in full year 2022: Adjusted EBITDA decrease of 9% versus 2021 due to continuing cost inflation, lockdowns in China and softer demand in non-healthcare marketsHealthCare IT: momentum created Significant improvement in order intake, both in terms of volume and in terms of quality, resulting in top line growth and stabilization of recurring revenueConversion of sales growth in EBITDA delayed by post-COVID reinvestments in
The Agfa-Gevaert Group in Q3 2022: Adjusted EBITDA increase of 8% with contrasted performances between the divisions HealthCare IT: organic sales growth, strong increase in order intake, solid profitabilityDigital Print & Chemicals: contrasted top line performance between the various activities – demand weakness and cost inflation impact – strong sales for Digital Print and Zirfon membranesRadiology Solutions: medical film business impacted by lockdowns in China and margin pressureOffset Solutio
Agfa's new membrane technology enables the most efficient, safe and sustainable production of green hydrogen Mortsel, Belgium – 19 October 2022 Agfa is proud to announce it received the essenscia Innovation Award 2022 for its groundbreaking Zirfon UTP 220 membrane technology for the most efficient, safe and sustainable production of green hydrogen. The prestigious award was presented by HRH Princess Astrid at the Square Convention Centre in Brussels yesterday evening. Pascal Juéry, CEO Agfa-Geva
Agfa sets a record as five of its inkjet printing solutions received a Pinnacle Product award from PRINTING United Alliance. The Pinnacle Product Awards recognize products that improve or advance the printing industry with exceptional contributions in quality, capability, and productivity. Carlstadt, NJ, USA / Mortsel, Belgium – September 26, 2022 “The fact that we outperformed competitors in every major print category that we play in, is a testament to our dedication to deliver innovative techn
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – September 1, 2022 – 5.40 p.m. CET According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%. In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration: Sheffield Asset Management,
Mortsel, Belgium – August 30, 2022 – 8.15 a.m. CET Within the framework of its ongoing transformation process, the Agfa-Gevaert Group has signed a share purchase agreement with AURELIUS Group for the sale of its Offset Solutions division. Under the terms of the agreement, AURELIUS Group would acquire the Offset Solutions division at an enterprise value of 92 million Euro, subject to customary working capital and net financial debt adjustments as well as minority share and net pension debt deduct
Q2 2022 AGFA Gevaert NV Earnings Call
Regulated information – August 24, 2022 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2022: Top line growth driven by Digital Print & Chemicals and Offset Solutions Order book HealthCare IT at very healthy level – strong growth in order intake Gross profit decreased due to inflationary pressure and volume losses in medical film related to COVID lockdowns in ChinaAdjusted EBITDA amounted to 32 million EuroSeasonal increase in working capital, amplified by supply chain issues, cost inflation and in
Mortsel, Belgium – July 5, 2022 – 5:40 p.m. CET Notification pursuant to Article 15 of the Act of 2 May 2007 concerning the disclosure of significant participations in issuers whose shares are admitted to trading on a regulated market As a result of the decision of the Board of Directors on March 8, 2022, the company, by notarial deed dated June 21, 2022, cancelled a total of 3,386,960 treasury shares. This decision was taken in accordance with the authorization granted to the Board of Directors
Mortsel, Belgium – June 13, 2022 – 5:40 p.m. CET Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels. The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020. Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maxi
Mortsel, Belgium – June 7, 2022 – 5:40 p.m. CET Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels. The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020. Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maxim